杜少静,李沐寒,贺慧颖.BCAR1在前列腺癌根治标本中的表达及其临床病理意义[J].肿瘤学杂志,2016,22(2):121-124.
BCAR1在前列腺癌根治标本中的表达及其临床病理意义
Expression of BCAR1 in Prostate Carcinoma and Its Clinicopathological Significance
投稿时间:2015-11-21  
DOI:10.11735/j.issn.1671-170X.2016.02.B009
中文关键词:  BCAR1  前列腺肿瘤  免疫组织化学  临床病理因素
英文关键词:BCAR1  prostate neoplasms  immunohistochemistry  clinicopathological parameters
基金项目:北京市重点学科基础医学学科建设项目(BMU20110254)
作者单位
杜少静 北京大学医学部基础医学院北京大学第三医院 
李沐寒 北京大学医学部基础医学院北京大学第三医院 
贺慧颖 北京大学医学部基础医学院北京大学第三医院 
摘要点击次数: 1790
全文下载次数: 842
中文摘要:
      摘 要:[目的] 探讨乳腺癌抗雌激素药物耐药蛋白BCAR1 在前列腺癌根治标本中的表达及其临床意义。[方法] 应用免疫组化法检测BCAR1在 97例前列腺癌根治标本中的表达情况,并分析其在肿瘤组织中的表达与各临床病理因素及预后的相关性。[结果] BCAR1在前列腺高级别上皮内瘤变(HGPIN)和前列腺癌组织中的表达显著高于癌旁前列腺组织(P<0.01)。并且BCAR1在癌组织中高表达与高Gleason评分之间存在显著相关性(χ2=6.987,P=0.008)。但BCAR1的表达与血清PSA水平、肿瘤体积、TNM分期及生物学复发之间均无显著相关性(P>0.05)。[结论] BCAR1的表达与前列腺癌的分化程度呈负相关,BCAR1可能在前列腺癌的发生过程中发挥作用。
英文摘要:
      Abstract:[Purpose] To investigate the expression of BCAR1 in prostate cancer and its clinicopathological significance. [Methods] The immunohistochemistry was used to detect the expression of BCAR1 in 97 cases of radical prostatectomy,and its relationship with clinicopathological features and biochemical recurrence were analyzed. [Results] BCAR1 expression was significantly higher in prostate carcinomas and HGPIN tissues than that in paracancerous tissues(P<0.05).There was significant correlation between BCAR1 expressions and the Gleason score(χ2=6.987,P=0.008).However,no significant correlations were found between BCAR1 expression and the other clinicopathological factors,including serum PSA,TNM stage,tumor volume and biochemical recurrence(P>0.05).[Conclusions] The expression level of BCAR1 is negatively associated with the differentiation of prostate carcinoma. BCAR1 may be participate in the development of prostate carcinoma.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器